Memantine and prevention of worsening in functional communication: post hoc analysis of a randomized, placebo-controlled trial in patients with moderate Alzheimer's disease

被引：0
|
作者：
Graham, S. M. [1 ]
Tocco, M. [1 ]
Hendrix, S. [2 ]
Hofbauer, R. K. [1 ]
Perhach, J. L. [1 ]
机构：
[1] Forest Res Inst, Jersey City, NJ USA
[2] Pentara Corp, Salt Lake City, UT USA
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2010年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：355 / 355
页数：1
相关论文
共 50 条
  • [1] Effects of memantine on functional communication in moderate Alzheimer's disease: results of a 12-week placebo-controlled trial
    Graham, S.
    Saxton, J.
    Woodward, M.
    Gilchrist, N.
    Potocnik, F.
    Hofbauer, R. K.
    Yu, S. Y.
    Hsu, H.
    Perhach, J. L.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 : S624 - S624
  • [2] Optimal Dosing of Galantamine in Patients with Mild or Moderate Alzheimer's Disease Post Hoc Analysis of a Randomized, Double-Blind, Placebo-Controlled Trial
    Aronson, Stephen
    Van Baelen, Bart
    Kavanagh, Shane
    Schwalen, Susanne
    DRUGS & AGING, 2009, 26 (03) : 231 - 239
  • [3] A randomized, double-blind, placebo-controlled trial of memantine in a behaviorally enriched sample of patients with moderate-to-severe Alzheimer's disease
    Herrmann, Nathan
    Gauthier, Serge
    Boneva, Neli
    Lemming, Ole Michael
    INTERNATIONAL PSYCHOGERIATRICS, 2013, 25 (06) : 919 - 927
  • [4] Randomized placebo-controlled trial of memantine for dementia in Parkinson's disease
    Marsh, L.
    Biglan, K.
    Williams, J. R.
    PARKINSONISM & RELATED DISORDERS, 2009, 15 : S82 - S82
  • [5] Randomized Placebo-controlled Trial of Memantine for Dementia in Parkinson's Disease
    Marsh, Laura
    Biglan, Kevin M.
    Williams, James R.
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2010, 18 (03): : S78 - S79
  • [6] Functional communication in patients with moderate Alzheimer's disease treated with memantine
    Graham, S.
    Tocco, M.
    Hendrix, S.
    Hofbauer, R. K.
    Perhach, J. L.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2010, 20 : S557 - S558
  • [7] Effects of memantine on functional communication in patients with moderate AD: results of a 12-week placebo-controlled trial
    Graham, S.
    Saxton, J.
    Woodward, M.
    Gilchrist, N.
    Potocnik, F.
    Hofbauer, R. K.
    Yu, S. Y.
    Hsu, H-A.
    Perhach, J. L.
    EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 : 346 - 346
  • [8] Memantine treatment in patients with mild to moderate Alzheimer's disease already receiving a cholinesterase inhibitor: A randomized, double-blind, placebo-controlled trial
    Porsteinsson, Anton P.
    Grossberg, George T.
    Mintzer, Jacobo
    Olin, Jason T.
    CURRENT ALZHEIMER RESEARCH, 2008, 5 (01) : 83 - 89
  • [9] A multinational, randomized, double-blind, placebo-controlled trial of memantine extended-release capsule in patients with moderate to severe Alzheimer's disease
    Grossberg, George T.
    Manes, Facundo
    Allegri, Ricardo
    Robledo, Luis Miguel Gutierrez
    Gloger, Sergio
    Xie, Lei
    Jia, Xinwei Daniel
    Perhach, James
    Graham, Stephen M.
    ANNALS OF NEUROLOGY, 2008, 64 : S41 - S42
  • [10] Memantine treatment of cognitive symptoms in mild to moderate Alzheimer disease: Secondary analyses from a placebo-controlled randomized trial
    Pomara, Nunzio
    Ott, Brian R.
    Peskind, Elaine
    Resnick, E. Malca
    ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2007, 21 (01): : 60 - 64
12345